abstract |
FIELD: immunology.SUBSTANCE: there are presented isolated antibodies able to specifically bind IL-33. Invention also covers a nucleic acid molecule, a composition and a cell. What is also described is a method of treating a disorder which is susceptible to inhibiting IL-33.EFFECT: present invention can find further application in therapy of various conditions, in particular autoimmune diseases and cancer.25 cl, 9 dwg, 1 tbl, 5 ex |